Member Exclusive News

The week in industry: Recardio to halt UK heart trial due to Brexit uncertainty

Read our round-up of some of the breaking news from the pharmaceutical industry over the past week. This week: Lilly acquires rights to Chugai's experimental diabetes drug and the USA and Cuba announce first joint biotech venture.

Go to the profile of RxNet
Oct 04, 2018
0
0

Please sign in or register for FREE

No comments yet.